World News
-
Aldeyra Therapeutics acquires Helio Vision
World | News | 0 Comment | 31 Jan, 2019
Aldeyra Therapeutics, a biotechnology company developing and commercializing next-generation medicines for immune-mediated diseases has announced that it has acquired Helio Vision, a privat...Read more
-
Medtronic announces launch of Mazor X Stealth
World | News | 0 Comment | 31 Jan, 2019
Ireland based Medtronic has announced the first U.S. patients treated with the Mazor X Stealth(TM) Edition for spine surgery following its recent commercial launch. The system was first us...Read more
-
World | News | 0 Comment | 31 Jan, 2019
Applied Health Signals company, Livongo Health has announced that it has signed a definitive agreement to acquire Denver-based myStrength which is a provider of digital behavioral heal...Read more
-
Pfizer and Lilly announce top-line results of Tanezumab
World | News | 0 Comment | 31 Jan, 2019
Pfizer and Eli Lilly have announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg in patients with moderate-to-severe osteoarthritis (OA) pain. As per ...Read more
-
Global Medicine spending to exceeds $1.5 Tn by 2023
World | News | 0 Comment | 31 Jan, 2019
Total spending on medicines is expected to top $1.5 trillion by 2023, up 50 percent from 2014, even as annual growth moderates at 3-6 percent on an annual compound basis compared to 6.3 per...Read more
-
Ionis, Roche initiates pivotal study of RG6042 for Huntington's disease
World | News | 0 Comment | 30 Jan, 2019
Ionis Pharma, Inc. the leader in antisense therapeutics, has announced that its partner Roche has enrolled the first patient in a pivotal study of RG6042 (IONIS-HTTRx) for people livin...Read more
-
Thermo Fisher to sell anatomy pathological biz
World | News | 0 Comment | 30 Jan, 2019
Thermo Fisher Scientific Inc., the world leader in serving science, has signed a definitive agreement to sell its Anatomical Pathology business to PHC Holdings Corporation, a global innovat...Read more
-
Zimmer Biomet receives FDA Clearance for ROSA
World | News | 0 Comment | 29 Jan, 2019
Zimmer Biomet, a global leader in musculoskeletal healthcare has announced U.S. Food and Drug Administration 510(k) clearance of the ROSA® Knee System for robotically-ass...Read more
-
Frost & Sullivan divulges top growth opportunities in Healthcare
World | News | 0 Comment | 29 Jan, 2019
By the end of 2019, up to 15 percent of the global healthcare spending is expected to be directed toward value-based care concepts. This will cause a surge in the number of risk-sharin...Read more
-
NIAID-sponsored trial of Ebola vaccines begins at Cincinnati Children's Hospital
World | News | 0 Comment | 29 Jan, 2019
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United Sta...Read more
-
Amanda Rangel Joins VirTrial as VP
World | News | 0 Comment | 29 Jan, 2019
VirTrial, a leading telehealth platform provider for virtual clinical trials, has named Amanda Rangel as VP of Business Development. “Having worked with Amanda for the past 10 years,...Read more
-
Dicerna announces start of Ph1 clinical trial of DCR-HBVS
World | News | 0 Comment | 29 Jan, 2019
Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the first human volunteer in its Phase 1 clinical trial of DCR-HBVS, the ...Read more
-
Intensive lowering of blood pressure can have a measurable impact on MCI, says a NIH research
World | News | 0 Comment | 29 Jan, 2019
Intensive lowering of blood pressure did not significantly reduce dementia risk but did have a measurable impact on mild cognitive impairment (MCI), according to the final, peer-reviewed re...Read more
-
G-CON collaborates with GE Healthcare
World | News | 0 Comment | 29 Jan, 2019
G-CON Manufacturing, the leader in prefabricated flexible cleanroom solutions and GE Healthcare plan to collaborate to improve cell therapy and viral vector manufacturing by providing drug ...Read more
-
J&J announces USFDA approval of IMBRUVICA
World | News | 0 Comment | 29 Jan, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of IMBRUVICA® (ibrutinib) in combination with obinu...Read more
-
World | News | 0 Comment | 28 Jan, 2019
Abcam, a global innovator in life science reagents and tools has announced its acquisition of Calico Biolabs, a developer of custom high-quality recombinant rabbit monoclonal antibodies for...Read more
-
Roya.com partners with Compliancy Group
World | News | 0 Comment | 28 Jan, 2019
Roya.com is pleased to announce a new Partnership with Compliancy Group offering medical professionals HIPAA Compliant, AMP powered custom websites Roya.com, an industry leader for custom ...Read more
-
Torque announces new appointments
World | News | 0 Comment | 28 Jan, 2019
Torque, an immuno-oncology company developing first-in-class Deep-Primed T Cell Therapeutics to direct immune power deep within the tumor microenvironment has announced the appointment of J...Read more
